The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01E | Antiglaucoma preparations and miotics | |
| 4 | S01EE | Prostaglandin analogues | |
| 5 | S01EE03 | Bimatoprost |
| Active Ingredient | Description | |
|---|---|---|
| Bimatoprost |
Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EYREIDA Eye drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| LATISSE Eyes drops, solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| LUMIGAN Eye drops, solution | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
